Best Pharma Strategies from the Experts

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

At one point in his career, I Don’t Care Host Kevin Stevenson spent some time on the pharma side of things, in between working at hospitals.

Today he dives back into that world with Donovan Quill, President, and CEO at Optime Care, a nationally recognized pharmacy, distribution, and patient management organization that creates the trusted path to a fulfilled life for patients with rare and orphan disorders.

“What we try to do is create a holistic program for those patients where we combine all the services you would see in a pharmacy in a patient care model,” Quill said. “We try to create a one-stop-shop for patients to really get the care they need from a support standpoint, from affordability, and also to distribute their products to them in their home or site of care.”

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand.” – Donovan Quill

Orphan disorders and drugs are a bit different from regular pharmaceuticals. Typically, an orphan drug is a treatment for a condition with less than 200,000 patients in the U.S., according to the FDA definition. But, what they do at Optime Care is treat disorders that are even more rare, or “Ultra orphan,” according to Quill.

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand,” Quill said. “We really try to focus on the patients who need a little extra care.”

Most of the time, the patients they treat have a disorder they’ve never heard of and are treated with a product they can’t pronounce, Quill said jokingly.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

NBA
Slow Stories in a Fast League: Why the NBA Still Deserves Real, In-Depth Journalism
November 3, 2025

In a sports world increasingly defined by short-form clips, social algorithms, and viral takes, long-form storytelling remains a vital counterweight — the place where depth, nuance, and narrative still matter. The NBA, perhaps more than any other league, sits at the center of this tension: every quote can become a meme, every story a highlight…

Read More
skate
The Faith-Fueled Story Behind Camp Arnold Skate Church’s Mission to Reach Youth Through Skateboarding
November 2, 2025

As faith-based outreach evolves to meet younger generations where they are, skate culture has become an unlikely — yet powerful — frontier for transformation. In cities like Dallas, skateparks are serving as modern-day meeting grounds where faith, mentorship, and authenticity intersect. With youth mental health challenges on the rise — the CDC reports that…

Read More
sepsis
The Answers You Wanted On Sepsis – Episode 3
October 31, 2025

In episode three of The Michael Rothman Podcast, Dr. Rothman continues his deep dive into sepsis—a condition often misunderstood yet responsible for a significant portion of hospital deaths. Through data from a major northeastern hospital, he challenges traditional thinking: labeling a patient as “septic” isn’t what determines survival—their overall sickness is. Using the…

Read More
costume contacts
A Spooky Warning About Costume Contacts
October 31, 2025

As we get into the Halloween spirit, many are looking for that perfect finishing touch for their costumes, and cosmetic contact lenses are a popular choice. However, Dr. Emily Eisenhower offers a timely warning: while they may look great, these lenses can pose serious vision risks. She cautions that improper lenses can lead to…

Read More